Is Eli Lilly and Company overvalued?

Eli Lilly and Company (LLY) looks overvalued — trading about 60% above its fair value.

Overvalued

Price

$1443.50

Fair value

$580.61

Current P/E

62.9

Normal P/E

25.3

Market cap

$1.36T

Dividend yield

0.5%

Return on equity

83.6%

Sector

Healthcare

Fair value compares LLY's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks